Doxime acquires AI Startup Pathway Medical for $ 63 million

Access dives deeper in Artificial intelligenceAnnouncing Thursday on the acquisition of Medical Start Way for $ 63 million.

The path has built a clinical tool that works on AI, which doctors can use to ask questions about recommendations, drugs and trials. Pathway’s answers are synthesized from medical literature, and Doximity said the Montreal startup has one of the largest structured data sets in medicine.

The Doxistinity platform that has been called as LinkedIn for doctorsHelps clinicians to remain aware of medical news, manage documents, find referrals and perform health care meetings with patients. Thanks to the acquisition of the path, Doxivy hopes the doctors will also turn to the platform to answer their clinical questions.

“We hunted high and low, and I think we found the best company in the space, answering the questions of doctors using AI, and it was not in Silicon Valley,” CNBC Juff Tangney said, co-founder and CEO of Doxity.

The transaction closed in late July to consider $ 26 million and up to $ 37 million in capital, Doxivy said.

Tangney noted that the integration of Doxity with Pathway is already coming, and companies check the combined product with thousands of doctors.

DoxiMity already has a free AI product, Doxivy GPT, which doctors can use to create insurance sheets and generalizing diagrams and patients reports. The way will lead to additional “reliability” to the data available at the back, said Dr. Ful, Chief Officer of the Clinical Doxity Experience.

“What a path brings this party or in this marriage is that they have a very, very reliable set of data that connects the dosage with the recommendations with the literature with quotes,” Ful said in an interview with CNBC.

The Pathway Model scored 96% at the American medical stage, said Doximity, which doctors should take to prove what they understand and can apply medical knowledge.

The DoxiMity, which became publicly available in 2021, increased by 8% this year after 90% increased in 2024. The company has a market capitalization of about $ 11 billion.

DoxiMity conducts its quarterly conference bill with investors to discuss their financial first quarter results on Thursday at 5 pm.